[go: up one dir, main page]

HK1223824A1 - 含有抗菌劑和抗炎劑的用於眼內給藥的藥劑組成 - Google Patents

含有抗菌劑和抗炎劑的用於眼內給藥的藥劑組成

Info

Publication number
HK1223824A1
HK1223824A1 HK16112015.8A HK16112015A HK1223824A1 HK 1223824 A1 HK1223824 A1 HK 1223824A1 HK 16112015 A HK16112015 A HK 16112015A HK 1223824 A1 HK1223824 A1 HK 1223824A1
Authority
HK
Hong Kong
Prior art keywords
agent
pharmaceutical compositions
intraocular administration
antiinflammatory
antibacterial agent
Prior art date
Application number
HK16112015.8A
Other languages
English (en)
Inventor
T Liegner Jeffery
Scott KAROLCHYK John
Covalesky Bernard
Dilzer Richard
Peters Kallan
Original Assignee
Imprimis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50640013&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1223824(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Imprimis Pharmaceuticals Inc filed Critical Imprimis Pharmaceuticals Inc
Publication of HK1223824A1 publication Critical patent/HK1223824A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK16112015.8A 2013-07-22 2016-10-18 含有抗菌劑和抗炎劑的用於眼內給藥的藥劑組成 HK1223824A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361958170P 2013-07-22 2013-07-22
PCT/US2014/032026 WO2015012899A1 (en) 2013-07-22 2014-03-27 Pharmaceutical compositions for intraocular administration comprising an antibacterial agent and an antiinflammatory agent

Publications (1)

Publication Number Publication Date
HK1223824A1 true HK1223824A1 (zh) 2017-08-11

Family

ID=50640013

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16112015.8A HK1223824A1 (zh) 2013-07-22 2016-10-18 含有抗菌劑和抗炎劑的用於眼內給藥的藥劑組成

Country Status (11)

Country Link
US (1) US20150024996A1 (zh)
EP (1) EP3024475B8 (zh)
JP (5) JP2016525544A (zh)
KR (1) KR20160033213A (zh)
AU (1) AU2014293665B2 (zh)
BR (1) BR112016001544A8 (zh)
CA (1) CA2919081C (zh)
HK (1) HK1223824A1 (zh)
IL (1) IL243750A0 (zh)
MX (1) MX2016000964A (zh)
WO (1) WO2015012899A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
US20160279055A1 (en) 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
JP6682898B2 (ja) * 2016-02-17 2020-04-15 富士通株式会社 基地局、無線通信システムおよび基地局の処理方法
JP6694525B2 (ja) * 2016-05-06 2020-05-13 ハーロウ・ヘルス・インコーポレイテッドＨａｒｒｏｗ Ｈｅａｌｔｈ， Ｉｎｃ． 薬学的眼病用組成物およびそれを製造するための方法
ES2909236T3 (es) 2016-11-16 2022-05-05 Persica Pharmaceuticals Ltd Formulaciones de antibióticos para el dolor lumbar
US11071724B2 (en) 2019-05-17 2021-07-27 Ocular Science, Inc. Compositions and methods for treating presbyopia
US12016855B2 (en) 2020-08-26 2024-06-25 Somerset Therapeutics, Llc Prednisolone and moxifloxacin compositions and methods
US11510930B2 (en) 2020-08-26 2022-11-29 Somerset Therapeutics, Llc Gatifloxacin, prednisolone, and bromfenac compositions and methods
US11523987B2 (en) 2020-08-26 2022-12-13 Somerset Therapeutics, Llc Trimcinolone and moxifloxacin methods
US12102632B2 (en) 2020-08-26 2024-10-01 Somerset Therapeutics, Llc Quinolone dispersions
EP4260844A1 (en) 2022-04-11 2023-10-18 Liegner, Jeffery T. Ophthalmological compositions comprising poloxamer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1192368A (ja) * 1997-07-23 1999-04-06 Ono Pharmaceut Co Ltd ベンゾピラン誘導体を主成分とする水性液剤
US6378526B1 (en) * 1998-08-03 2002-04-30 Insite Vision, Incorporated Methods of ophthalmic administration
JP2003176228A (ja) * 2001-12-11 2003-06-24 Rohto Pharmaceut Co Ltd 液 剤
US20070049552A1 (en) * 2003-04-14 2007-03-01 Babu Manoj M Fluoroquinolone formulations and methods of making and using the same
PT1885336E (pt) * 2005-05-10 2009-05-07 Alcon Inc Formulações de suspensão compreendendo um princípio activo, um tensoactivo poloxâmero ou meroxapol e um glicol, sua utilização no fabrico de um medicamento para tratamento de distúrbios oftálmicos
US20080262415A1 (en) * 2005-07-18 2008-10-23 Peyman Gholam A Enhanced wound healing
EP2962682B1 (en) * 2008-12-11 2018-03-28 Massachusetts Institute Of Technology Method of making a contact lens drug delivery device
JP2013508381A (ja) * 2009-10-21 2013-03-07 オトノミ―，インク． ポロクサマーを包含する製剤のゲル化温度の調節
US20120277199A1 (en) * 2009-10-21 2012-11-01 Otonomy, Inc. Modulation of Gel Temperature of Poloxamer-Containing Formulations
US20140127269A1 (en) * 2012-02-13 2014-05-08 The Schepens Eye Research Institute, Inc. Anti-Inflammatory Peptide Derived From Thrombospondin-1 and Uses Thereof

Also Published As

Publication number Publication date
KR20160033213A (ko) 2016-03-25
WO2015012899A1 (en) 2015-01-29
CA2919081A1 (en) 2015-01-29
JP2019167376A (ja) 2019-10-03
EP3024475B1 (en) 2020-09-30
MX2016000964A (es) 2016-08-03
US20150024996A1 (en) 2015-01-22
BR112016001544A8 (pt) 2021-08-03
AU2014293665A1 (en) 2016-02-11
NZ716208A (en) 2020-12-18
JP2024001149A (ja) 2024-01-09
EP3024475A1 (en) 2016-06-01
CA2919081C (en) 2021-11-16
AU2014293665B2 (en) 2017-06-01
BR112016001544A2 (pt) 2017-07-25
JP2016525544A (ja) 2016-08-25
JP7232128B2 (ja) 2023-03-02
IL243750A0 (en) 2016-04-21
JP2022185059A (ja) 2022-12-13
JP7362870B2 (ja) 2023-10-17
EP3024475B8 (en) 2020-11-18
JP2021121608A (ja) 2021-08-26

Similar Documents

Publication Publication Date Title
HK1223824A1 (zh) 含有抗菌劑和抗炎劑的用於眼內給藥的藥劑組成
IL240290A0 (en) History of pyridazinone-amide and pharmaceutical preparations containing them
EP3043824A4 (en) Modified therapeutic agents and compositions thereof
EP3082817A4 (en) Compositions for drug administration
IL243608A0 (en) Substances with antiviral activity, preparations containing them and their uses
PT3043773T (pt) Composição farmacêutica de dose fixa estável composta por mometasona e olopatadina para administração nasal
HK1212899A1 (zh) 包含癌莫事 之醫藥組合物
HK1215191A1 (zh) 低劑量醫藥組合物
IL244687A0 (en) Epinephrine-based ophthalmic preparations for intraocular administration and methods for their production
SG10201801848UA (en) Hypertonic antimicrobial therapeutic compositions
HK1211021A1 (zh) -取代- -聯芳基甲基氨基- -環戊基- -嘌呤衍生物、其作為藥物的用途及藥物組合物
ZA201401683B (en) Pharmaceutical compositions for rectal administration
PL3064491T3 (pl) Pochodna sulfonamidowa i jej zastosowanie medyczne
EP2987786A4 (en) AMIDOPYRIDINOL DERIVATIVE OR PHARMACEUTICAL, SALT AND PHARMACEUTICAL COMPOSITION THEREFOR AS ACTIVE SUBSTANCE
ZA201507576B (en) Pharmaceutical combination drug
EP3020417A4 (en) Pharmaceutical composition for respiratory administration
EP2994755A4 (en) Therapeutic and imaging compositions and uses thereof
HK1219691A1 (zh) 醫藥組成物及其用途
EP2968698A4 (en) COMPOUNDS AND COMPOSITIONS FOR RELEASE OF MEDICAMENT
IL240666A0 (en) Pharmaceutical preparations for oral administration and their uses
SG11201509194SA (en) Radiomitigating pharmaceutical formulations
HUP1300496A2 (hu) Stabil kombinációs gyógyszerkészítmény
PT3060213T (pt) Composições farmacêuticas compreendendo agentes antibacterianos
IL244316A0 (en) A new composition of a drug
GB201318635D0 (en) Preservative free pharmaceutical compositions for ophthalmic administration